Syndax is committed to helping patients who have not had success with existing, available therapies and may benefit from our investigational therapies currently in development. The Syndax Policy for Access to Investigational Agents describes the principles and procedures that the company will follow when considering a request. Requests for compassionate use should be made through the patient’s treating physician. Please see below for further details.